Results 211 to 220 of about 194,896 (346)

Pre‐Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS‐CoV‐2 Inactivated Vaccines

Advanced Science, Volume 13, Issue 6, 30 January 2026.
Challenging the focus on age, this study finds pre‐existing T helper 1 cells are the key biomarker for predicting antibody response to SARS‐CoV‐2 inactivated vaccines. In both mice and humans, high responders exhibited elevated baseline T helper 1 cells, which correlated with robust humoral immunity, offering crucial guidance for improving vaccine ...
Chanyuan Ye, Xiaoli Zhang, Lingfeng Qiu, Jia Ji, Jueqing Gu, Hongyu Jia, Yingfeng Lu, Jiyang Chen, Zelu Meng, Jiangshan Lian, Hangping Yao, Xun Zeng, Yida Yang   +12 more
wiley   +1 more source

Characterizing the interactions between influenza and respiratory syncytial viruses and their implications for epidemic control. [PDF]

Nat Commun
Kramer SC, Pirikahu S, Casalegno JS, Domenech de Cellès M.   +3 more
europepmc   +1 more source

Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011–2016 in southern China [PDF]

, 2019
Hong-jiao Luo, Xubin Huang, Huiling Zhong, Congxiu Ye, Xin Tan, Kai Zhou, Lei Yuan, Su-fen Zhang, Xun Zhu, Cuiji Lin, Wenjun Wang, Lin Xu, Kaiyuan Cao   +12 more
openalex   +1 more source

SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

European Journal of Immunology, Volume 56, Issue 1, January 2026.
SARS‐CoV‐2 mRNA vaccination triggers bystander activation of B cells, transiently increasing antibody levels after the first vaccination against influenza, RSV, and tetanus. Reactivation of B cell responses also occurred, where (CD11c+) MBC and DN3 are expanded after SARS‐CoV‐2 mRNA vaccination, independent of antigen exposure.
Lisan H. Kuijper, Laura Y. L. Kummer, Laura Fernandez Blanco, Karlijn van der Straten, Mathieu A. F. Claireaux, Amélie V. Bos, Miranda C. Dieker‐Meijer, Tineke Jorritsma, Mariël C. Duurland, Maurice Steenhuis, Juan J. Garcia Vallejo, Koos P. J. van Dam, Eileen W. Stalman, Luuk Wieske, Sander W. Tas, Laura Boekel, Gert‐Jan Wolbink, Theo Rispens, Taco W. Kuijpers, Filip Eftimov, Marit J. van Gils, Anja ten Brinke, S. Marieke van Ham, T2B! immunity against SARS‐CoV‐2 study group   +23 more
wiley   +1 more source

Simultaneous Detection and Differentiation of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Viruses in Respiratory Specimens Using the VitaSIRO <i>solo</i>™ SARS-CoV-2/Flu/RSV Assay. [PDF]

Diagnostics (Basel)
Mboumba Bouassa RS, Lukumbisa S, Bélec L.   +2 more
europepmc   +1 more source

Impact of Real-Time, On-Demand Influenza and Respiratory Syncytial Virus Testing at Point-of-Care on Antibiotic Prescribing and Clinical Outcome in Pediatric Outpatients With Acute Respiratory Illness: A Prospective, Quasi-Randomized, Controlled Study. [PDF]

Influenza Other Respir Viruses
ABSTRACT Background Rapid and accurate detection and identification of viral pathogens have an impact on physician decision‐making for patients with acute respiratory illness (ARI). We aimed to evaluate the Xpert Xpress Flu/RSV test for the management of antibiotic prescribing in pediatric outpatients with ARI. Methods We performed a prospective, quasi‐
Xie Y, Chen T, Liu B, Xiao H, Gao X, Li Q, Hu B, Liu C, Zhao C, Li Y, Xu X, Li M, Tang YW, Liu G.   +13 more
europepmc   +2 more sources

Concurrent detection of other respiratory viruses in children shedding viable human respiratory syncytial virus [PDF]

Journal of Medical Virology, 2013
T.B. Gagliardi, F.E. Paula, M.A. Iwamoto, J.L. Proença-Modena, A.E. Santos, A.A. Camara, M.C. Cervi, O.A.L. Cintra, E. Arruda   +8 more
openaire   +1 more source

Efficacy and Safety of Ecklonia cava Kjellman Extract Complex in Respiratory Health: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Clinical Trial

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
This study evaluated the efficacy and safety of Ecklonia cava Kjellman extract complex (EEC) in respiratory health through a randomized clinical trial. Compared to the placebo group, the EEC group showed significant improvements in breathlessness, cough, and sputum scale (BCSS) including total, breathlessness, and sputum scores, visual analogue scale ...
Seong‐Cheon Woo, Su Won Lee, Jayun Kim, In Chul Jung, Ji Woong Son, Beom‐Joon Lee, Sang Oh Kwon, Jung‐Hee Byeon, Yang Chun Park   +8 more
wiley   +1 more source

Genomic characterization of circulating human respiratory syncytial viruses A and B in Kuwait using whole-genome sequencing. [PDF]

Microbiol Spectr
Madi N, Safar HA, Al-Adwani A, Sadeq M, Al-Turab M.   +4 more
europepmc   +1 more source

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice [PDF]

Guangxu Ma, Zeping Xu, Chinyu Li, Feng Zhou, Branda Hu, Junwei Guo, Changwen Ke, Liqing Chen, Guilin Zhang, Hungyan Lau, Hudan Pan, Xixin Chen, Runze Li, Liang Liu   +13 more
openalex   +1 more source